NGM - NGM Biopharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts4434
Avg. Estimate-0.29-0.4-1.02-1.23
Low Estimate-0.4-0.56-1.17-1.58
High Estimate-0.22-0.28-0.79-0.97
Year Ago EPSN/AN/AN/A-1.02
Revenue EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts3333
Avg. Estimate18.49M13.43M82.5M83.33M
Low Estimate12.1M5M75M75M
High Estimate24.37M23.2M97.5M100M
Year Ago SalesN/AN/AN/A82.5M
Sales Growth (year/est)N/AN/AN/A1.00%
Earnings HistoryInvalid DateInvalid Date3/30/20196/29/2019
EPS Est.N/AN/A-0.28-0.24
EPS ActualN/AN/A-1.21-0.13
DifferenceN/AN/A-0.930.11
Surprise %N/AN/A-332.10%45.80%
EPS TrendCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.29-0.4-1.02-1.23
7 Days Ago-0.28-0.35-1.08-1.12
30 Days Ago-0.28-0.35-1.08-1.23
60 Days Ago-0.25-0.34-1.08-1.27
90 Days Ago-0.25-0.34-1.08-1.27
EPS RevisionsCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Up Last 7 Days3231
Up Last 30 Days3233
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/A1N/AN/A
Growth EstimatesNGMIndustrySectorS&P 500
Current Qtr.N/AN/AN/A-0.00
Next Qtr.N/AN/AN/A0.08
Current YearN/AN/AN/A0.03
Next Year-20.60%N/AN/A0.10
Next 5 Years (per annum)N/AN/AN/A0.08
Past 5 Years (per annum)N/AN/AN/AN/A